Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.
Int J Mol Sci. 2023 Jan 8;24(2):1239. doi: 10.3390/ijms24021239.
Int J Mol Sci. 2023.
PMID: 36674755
Free PMC article.
Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies.
V Kholodenko I, V Kalinovsky D, V Svirshchevskaya E, I Doronin I, V Konovalova M, V Kibardin A, V Shamanskaya T, S Larin S, M Deyev S, V Kholodenko R.
V Kholodenko I, et al. Among authors: v konovalova m.
Molecules. 2019 Oct 24;24(21):3835. doi: 10.3390/molecules24213835.
Molecules. 2019.
PMID: 31653037
Free PMC article.
Item in Clipboard
Cite
Cite